IEQ Capital’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-237,962
Closed -$293K – 2139
2026
Q2
$293K Buy
237,962
+122,762
+107% +$122K ﹤0.01% 1650
2026
Q1
$80.9K Buy
115,200
+103,075
+850% +$96.2K ﹤0.01% 1816
2025
Q4
$18.8K Sell
12,125
-8,248
-40% -$13.2K ﹤0.01% 1829
2025
Q3
$32.2K Buy
20,373
+6,492
+47% +$11.3K ﹤0.01% 1815
2025
Q2
$30.3K Buy
13,881
+2,804
+25% +$6.79K ﹤0.01% 1785
2025
Q1
$30.2K Buy
+11,077
New +$43.7K ﹤0.01% 1574

Other funds holding MXCT

IEQ Capital's MXCT Position: Q3 2026 in Review

IEQ Capital sold out of MaxCyte (MXCT) in Q3 2026, closing a stake of 237,962 shares — an estimated $293K sold.

IEQ Capital first reported a position in MXCT in Q1 2025 and held it in 6 quarters. The position peaked at $293K in Q2 2026. 118 funds tracked by Wall St. Rank hold MXCT as of Q3 2026.

  • IEQ Capital reported no remaining MaxCyte position as of Q3 2026 after selling out during the quarter.
  • IEQ Capital sold 237,962 MaxCyte shares in Q3 2026, an estimated $293K.
  • IEQ Capital first reported a position in MaxCyte in Q1 2025 and held it in 6 quarters.
  • IEQ Capital's MaxCyte position peaked at $293K in Q2 2026.
  • 118 funds tracked by Wall St. Rank held MaxCyte as of Q3 2026.

Based on IEQ Capital's 13F filing for Q3 2026, filed 10 Nov 2026.